Table 4. Overall scores by country, number of authors and topic of review.
No of
records |
For the 19 PRISMA-P items assessed | For the 63 elements assessed | |||||||
---|---|---|---|---|---|---|---|---|---|
Overall score
(% of possible score) |
Mean
score (SD) |
Median
score |
Range of
scores |
Overall
score (% of possible score) |
Mean
score (SD) |
Median
score |
Range of
scores |
||
Country (10 with most assessed records) | |||||||||
Australia | 33 | 179 (28) | 5.4 (2.1) | 5 | 2–11 | 1115 (54) | 33.8 (6.2) | 32 | 21–47 |
Brazil | 53 | 272 (27) | 5.1 (1.9) | 5 | 2–9 | 1826 (55) | 34.5 (6.0) | 35 | 18–46 |
Canada | 37 * | 197 (28) | 5.3 (2.1) | 5 | 2–9 | 1301 (56) | 35.2 (6.7) | 35 | 21–45 |
China | 101 | 418 (22) | 4.1 (1.3) | 4 | 2–10 | 3385 (54) | 33.5 (4.5) | 34 | 23–45 |
England | 46 | 259 (29) | 5.6 (2.2) | 5 | 2–10 | 1620 (55) | 35.2 (6.9) | 35.5 | 22–47 |
Germany | 11 * | 59 (28) | 5.4 (2.3) | 4 | 3–10 | 380 (55) | 34.5 (6.2) | 33 | 26–47 |
Italy | 15 | 71 (27) | 4.7 (1.8) | 4 | 3–9 | 499 (57) | 33.3 (6.2) | 32 | 24–47 |
Netherlands | 13 | 68 (28) | 5.2 (2.1) | 5 | 2–9 | 439 (53) | 33.8 (7.0) | 33 | 23–47 |
Spain | 13 | 64 (26) | 4.9 (1.8) | 4 | 2–7 | 426 (52) | 32.8 (5.6) | 33 | 22–42 |
USA | 48 | 242 (27) | 5.0 (2.2) | 4 | 2–10 | 1526 (51) | 31.8 (6.4) | 31 | 21–47 |
Number of authors | |||||||||
0–3 | 202 | 956 (25) | 4.7 (1.8) | 4 | 2–10 | 6648 (52) | 32.9 (5.9) | 32 | 18–47 |
4–6 | 179 | 867 (25) | 4.8 (1.9) | 5 | 2–11 | 6008 (53) | 33.6 (5.7) | 34 | 21–47 |
7+ | 52 | 258 (27) | 5.0 (1.9) | 4 | 2–9 | 1813 (56) | 34.9 (5.9) | 34 | 21–47 |
Topic of review (10 with most assessed records) | |||||||||
Cancer | 42 | 184 (23) | 4.4 (1.8) | 4 | 2–10 | 1326 (50) | 31.6 (5.6) | 31 | 21–47 |
Cardiovascular | 58 * | 278 (25) | 4.8 (1.8) | 4 | 2–10 | 1952 (53) | 33.7 (5.5) | 33 | 21–46 |
Complementary
therapies |
43 | 211 (26) | 4.9 (1.8) | 5 | 2–9 | 1511 (56) | 35.1 (6.0) | 36 | 22–44 |
Endocrine
and metabolic disorders |
34 * | 175 (27) | 5.1 (2.1) | 5 | 2–10 | 1204 (56) | 35.4 (6.1) | 36 | 21–47 |
Mental health
and behavioural conditions |
51 | 266 (27) | 5.2 (2.0) | 5 | 2–10 | 1762 (55) | 34.5 (5.7) | 33 | 21–44 |
Musculoskeletal | 70 | 335 (25) | 4.8 (2.0) | 4 | 2–11 | 2295 (52) | 32.8 (6.2) | 32 | 18–47 |
Neurological | 42 * | 221 (28) | 5.3 (1.9) | 5 | 2–11 | 1443 (55) | 34.4 (6.1) | 33.5 | 23–47 |
Physiotherapy | 36 | 174 (25) | 4.8 (1.8) | 4 | 2–8 | 1194 (53) | 33.2 (5.8) | 32.5 | 18–43 |
Rehabilitation | 42 * | 201 (25) | 4.8 (2.1) | 4 | 2–11 | 1393 (53) | 33.2 (5.7) | 32.5 | 23–47 |
Surgery | 49 | 251 (27) | 5.1 (1.8) | 5 | 2–10 | 1644 (53) | 33.6 (5.2) | 33 | 23–47 |
*numbers differ from Table 1 because of the record(s) excluded at assessment